News

April 27, 2020April 27, 2020

Benefits of Orenitram for PAH Patients Detailed in New Data

News, PAH News

United Therapeutics’ Orenitram (treprostinil) improves heart function and lowers risk status in people with pulmonary arterial hypertension (PAH) who had begun treatment with another approved therapy, new data from a Phase ... Read more

April 23, 2020April 24, 2020

FDA Grants Orphan Drug Designation to Cereno Scientific’s Lead Candidate CS1 for PAH

News, PAH News

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CS1, Cereno Scientific’s lead therapy candidate for the treatment of pulmonary arterial hypertension (PAH). CS1 is ... Read more

April 23, 2020April 23, 2020

NORD Opens COVID-19 Financial Aid Program for Rare Disease Community

News, syndicated

The National Organization for Rare Disorders (NORD) has opened a financial assistance program for people in rare disease community who are affected by the COVID-19 pandemic in the U.S. ... Read more

April 22, 2020April 22, 2020

Novel IPAH Mutations Found in Chinese Patients, Study Reports

News, PAH News

Newly identified mutations that contribute to a higher susceptibility of idiopathic pulmonary arterial hypertension (IPAH) in people from China, were found in a pathway commonly targeted by therapies that ... Read more

April 20, 2020April 21, 2020

Publisher’s Note: New Survey Aimed at PH Patients Not Currently on Treatment

News

Based on recently conducted surveys, we know there is a subset of patients with pulmonary hypertension who are currently not on therapies approved by the U.S. Food and Drug ... Read more

April 20, 2020April 20, 2020

LENUS Pro Pump for Remodulin May Need Monitoring of Flow Rate

News, PAH News

Tricumed‘s LENUS Pro pump, an implantable device approved in Europe for the long-term intravenous administration of Remodulin (treprostinil) to treat pulmonary arterial hypertension (PAH), does not maintain a steady flow ... Read more

April 17, 2020April 17, 2020

Exosomes from Stem Cells May Slow Vascular Remodeling in PAH

News, PH News

Small vesicles, called exosomes, released by mesenchymal stem cells helped to ease vascular remodeling in a rat model of pulmonary hypertension (PH), a study reports. The study “Mesenchymal stromal ... Read more

April 15, 2020April 15, 2020

FDA to Review Liquidia’s Application Requesting Approval of LIQ861 for PAH

News, PAH News

The U.S. Food and Drug Administration (FDA) has accepted for review the new drug application (NDA) Liquidia Technologies submitted earlier this year requesting marketing approval of LIQ861, its proprietary inhaled ... Read more

April 13, 2020April 13, 2020

Acceleron’s Sotatercept Granted FDA’s Breakthrough Therapy Status for PAH

News, PAH News

The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough therapy to Acceleron Pharma‘s investigational molecule sotatercept for the treatment of pulmonary arterial hypertension (PAH). Breakthrough designation is given ... Read more

April 10, 2020April 10, 2020

HELP Trial Testing Levosimendan Infusion in PH-HFpEF Patients Completed

News, PH News

Tenax Therapeutics has completed its Phase 2 HELP clinical trial testing levosimendan as a potential treatment for patients with pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF). Top-line trial ... Read more

Pin It on Pinterest